10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Kidney Cancer
5 articles
Subcutaneous Nivolumab: A Game-Changer for Advanced Kidney Cancer Treatment
Subcutaneous nivolumab proves noninferior to IV administration in advanced kidney cancer patients.
Unmasking the Risk Factors: New Insights into Immune-Mediated Hepatotoxicity in Cancer Immunotherapy
Meta-analysis reveals key risk factors for liver toxicity in cancer patients receiving immunotherapy
Immune Checkpoint Inhibitor Rechallenge: A New Hope for Cancer Patients
Meta-analysis shows ICI rechallenge may be safe and effective for some cancer patients who stopped treatment
Sex and Side Effects: New Study Explores Gender Differences in Cancer Immunotherapy
Meta-analysis investigates sex-based differences in adverse events for cancer patients on immunotherapy
Immunotherapy Rechallenge Falls Short in Advanced Kidney Cancer Trial
Phase 3 trial shows no benefit of adding immune checkpoint inhibitor to targeted therapy in RCC patients